AI Analysis
Log in to generate an AI summary for this stock.
Log in to generate a MOAT report for this stock.
Log in to generate an earnings report for this stock.
Log in to generate an operating leverage report for this stock.
Log in to generate a management report for this stock.
Log in to generate a valuation report for this stock.
Medifast, Inc.
Video analysis: MED
All videosNo video analysis for this stock yet. Request one from our team.
News: MED
Medifast's 3.0 Strategy Takes Shape: Can It Restore Profitable Growth?
MED is shifting toward metabolic health with its 3.0 strategy, targeting broader growth, greater efficiency and a return to profitability.
Why Is Medifast (MED) Down 7.6% Since Last Earnings Report?
Medifast (MED) reported earnings 30 days ago. What's next for the stock?
Ocius Technology to Add Sonar Systems to Bluebottle Fleet: NYSE Content Update
NYSE issues a pre-market daily advisory direct from the trading floor. NEW YORK, Sept.
Medifast® Announces the Launch of the Medifast Metabolic Health Institute™
BALTIMORE--(BUSINESS WIRE)--Medifast, Inc. (NYSE: MED) has announced the launch of the Medifast Metabolic Health Institute, established to advance metabolic health through rigorous research and credible, evidence-based education. The institute brings Medifast's clinical research, scientific expertise, and educational resources under a single body, solidifying the company's position in the metabolic health space. It follows the July launch of Trilivy™, which replaced OPTAVIA® as the company's co.
Can Medifast Capitalize on Rising GLP-1 Use With Metabolic Health?
MED's Trilivy launch marks a major metabolic-health shift, backed by a 10-year roadmap and growing GLP-1 market focus.
All You Need to Know About Medifast (MED) Rating Upgrade to Buy
Medifast (MED) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Great Lakes Advisors LLC Invests $548,000 in Medifast Inc $MED
Great Lakes Advisors LLC purchased a new position in shares of Medifast Inc (NYSE: MED) in the undefined quarter, according to its most recent filing with the Securities and Exchange Commission. The fund purchased 51,611 shares of the specialty retailer's stock, valued at approximately $548,000. Great Lakes Advisors LLC owned approximately 0.46% of
Can Medifast's New Compensation Plan Accelerate Coach Growth?
MED is reshaping its coach network around Executive Directors as productivity rises despite a sharp decline in active earning coaches.
Similar companies
-
Torrid Holdings Inc.
CURV
·
New York Stock Exchange
Compare
-
Bassett Furniture Industries, Incorporated
BSET
·
NASDAQ
Compare
-
Clarus Corporation
CLAR
·
NASDAQ
Compare
-
1stdibs.com, Inc.
DIBS
·
NASDAQ
Compare
-
China Automotive Systems, Inc.
CAAS
·
NASDAQ
Compare
-
Faraday Future Intelligent Electric Inc.
FFAI
·
NASDAQ
Compare